HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

[1]  S. Thompson,et al.  An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group. , 1986, International journal of epidemiology.

[2]  W. H. Wilkinson,et al.  Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. , 1986, Atherosclerosis.

[3]  S. Thompson,et al.  An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma , 1986, British Journal of Haematology.

[4]  M. C. Stone,et al.  Plasma fibrinogen--a major coronary risk factor. , 1985, The Journal of the Royal College of General Practitioners.

[5]  C. Bulpitt,et al.  Fibrinogen: a possible link between social class and coronary heart disease. , 1985, British medical journal.

[6]  I. Hjermann,et al.  A novel form of factor VII in plasma from men at risk for cardiovascular disease , 1985, British journal of haematology.

[7]  M. Samama,et al.  FURTHER EVIDENCE THAT ACTIVATED FACTOR VII IS RELATED TO PLASMA LIPIDS , 1985, British journal of haematology.

[8]  H. Schulte,et al.  Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause , 1985, Thrombosis and Haemostasis.

[9]  S. Thompson,et al.  The effect of physiological levels of fibrinogen on platelet aggregation. , 1985, Thrombosis research.

[10]  S. Thompson,et al.  Epidemiological characteristics of platelet aggregability. , 1985, British medical journal.

[11]  S. Thompson,et al.  Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIa in hyperlipidaemia, with possible implications for ischaemic heart disease , 1985, British journal of haematology.

[12]  T. Meade,et al.  Haemostasis in Normal Pregnancy , 1984, Thrombosis and Haemostasis.

[13]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[14]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[15]  T. Meade,et al.  Haemostatic changes following surgery. , 1983, Thrombosis research.

[16]  T. Meade,et al.  HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.

[17]  T. Meade,et al.  Common Units for Clotting Factors Assayed Against Different Standards , 1982, Thrombosis and Haemostasis.

[18]  T. Meade,et al.  Effect of high-fibre diet on haemostatic variables in diabetes. , 1982, British medical journal.

[19]  Elspeth B. Smith,et al.  HAEMOSTATIC FACTORS IN HUMAN AORTIC INTIMA , 1981, The Lancet.

[20]  T. Meade,et al.  Effect of treatment of hyperlipidaemia on haemostatic variables. , 1980, British medical journal.

[21]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[22]  S. Thompson,et al.  Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. , 1980, British medical journal.

[23]  I Hutton,et al.  Relation between extent of coronary artery disease and blood viscosity. , 1980, British medical journal.

[24]  P. Majerus,et al.  Purification and properties of human coagulation factor VII. , 1980, The Journal of biological chemistry.

[25]  T. Meade,et al.  Ischaemic heart disease mortality risks for smokers and non-smokers. , 1979, Journal of epidemiology and community health.

[26]  A. P. Haines,et al.  Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. , 1979, British medical journal.

[27]  T. Meade,et al.  Ethnic group comparisons of variables associated with ischaemic heart disease. , 1978, British heart journal.

[28]  T C Chalmers,et al.  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. , 1977, The New England journal of medicine.

[29]  T. Meade,et al.  HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGEN , 1977, The Lancet.

[30]  M. Esnouf.  Biochemistry of blood coagulation. , 1977, British medical bulletin.

[31]  T. Meade,et al.  Population-based distributions of haemostatic variables. , 1977, British medical bulletin.

[32]  M. Brozovīc.  Physiological mechanisms in coagulation and fibrinolysis. , 1977, British medical bulletin.

[33]  T. Meade,et al.  Factor VII in an Industrial Population , 1974, British journal of haematology.

[34]  S. Evensen,et al.  Endotoxin‐Induced Intravascular Coagulation and Shock in Dogs: The Role of Factor VII , 1974, British journal of haematology.

[35]  V. Beral.  ORAL-CONTRACEPTIVES AND HEALTH , 1974 .

[36]  W. Inman,et al.  Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs , 1970, British medical journal.

[37]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[38]  E. Loeliger,et al.  Behaviour of Factors II, VII, IX, and X during Long-Term Treatment with Coumarin , 1963, Thrombosis and Haemostasis.

[39]  S. Carrington.  The plasma fibrinogen levels in Gambian women and young children. , 1960, The West African medical journal.

[40]  V. Schrire,et al.  Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease , 1960, British medical journal.